ZURICH (Reuters) – Swiss drugs regulator Swissmedic said on Tuesday it approved the extension of a booster dose of Pfizer-BioNTech’s COVID-19 vaccine to everyone aged 16 years and over.
“This clears the way for wider use of the booster vaccination. High-risk individuals can still obtain a booster dose from age 12,” Swissmedic said in a statement.
(Reporting by Silke Koltrowitz, Editing by Louise Heavens)
